Miniaturization Strengthens the Adoption of Implantable Electronics in Medical Devices
May 15, 2017 | Frost & SullivanEstimated reading time: 2 minutes
The rapid expansion of diabetes testing and drug delivery markets is shining a spotlight on next-generation electronic devices such as implantable continuous glucose monitoring (CGM) and implantable infusion pumps. Medical device manufacturers’ keenness to harness the intensifying demand for miniaturized electronic devices has further prompted the introduction of cardiovascular implants that are compatible with imaging systems such as magnetic resonance imaging (MRI). These miniaturized implantable electronics will be digitally connected in the future to promote futuristic healthcare applications such as smarter drug delivery and painless diabetes testing. The fastest growing segment is, however, implantable neurostimulators due to their ability to treat multiple neurological disorders such as epilepsy, dementia, Alzheimer’s disease, Parkinson’s disease and dystonia.
Innovations in Implantable Electronics is part of Frost & Sullivan’s TechVision (Microelectronics) Growth Partnership Service program. The devices covered in this research include cardiovascular implantable electronic devices (CIEDs), cochlear implants, implantable neurostimulators, implantable CGM devices, implantable infusion pumps and retinal implants. The study also details the importance of insurance coverage in the higher uptake of active implantable electronics.
“The constant stream of innovations has attracted substantial private funding to the implantable electronics market, while public funding is expected to improve in the future,” noted Frost & Sullivan TechVision Industry Analyst Bhargav Rajan. “As the majority of the population seeking implants is from low- and middle-income groups, the success of implantable electronics is largely dependent on the reimbursement environment.”
Apart from North America and certain countries in Europe, the unfavorable reimbursement scenario has dented the prospects of implantable medical devices. Nevertheless, the radical upgrades in healthcare infrastructure in many developing nations, especially India, China, Brazil, Russia, Malaysia and Vietnam, have stoked huge demand for implantable electronics and a consequent need to expand their insurance coverage.
“Although the reimbursement for cochlear implants and CIEDs is strong, other devices, especially retinal implants and neurostimulators, are not covered completely by the insurers,” noted Rajan. “Besides, the cost of development of implantable devices is extremely high due to the complex nature of the systems, and this cost trickles down to the patients.”
To make optimum use of the market’s potential, technology developers need to work on lowering their development costs through collaborations with early stage start-ups and small- and medium-sized enterprises. This will allow them to gain cross-industry expertise and cutting-edge innovations, which will, in due course, help lower the price points.
About TechVision
Frost & Sullivan's global TechVision practice is focused on innovation, disruption and convergence, and provides a variety of technology-based alerts, newsletters and research services as well as growth consulting services. Its premier offering, the TechVision program, identifies and evaluates the most valuable emerging and disruptive technologies enabling products with near-term potential. A unique feature of the TechVision program is an annual selection of 50 technologies that can generate convergence scenarios, possibly disrupt the innovation landscape, and drive transformational growth.
About Frost & Sullivan
Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today's market participants. For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community.
Suggested Items
Electronics Industry Sentiment Rose in April, Hitting New High
05/02/2024 | IPCApril 2024 marked the third consecutive month of sentiment growth among electronics manufacturers. When asked if they expected labor costs for hourly workers to rise over the next month, manufacturers in the United States, Mexico, and Europe predicted a five percent increase, while manufacturers in Asia predicted a slightly lower four percent increase.
iNEMI Names Grace O'Malley CTO
05/02/2024 | iNEMIThe Board of Directors of the International Electronics Manufacturing Initiative (iNEMI) has named Grace O'Malley Chief Technical Officer (CTO).
ZESTRON Academy Launches 2024 Advanced Packaging & Power Electronics Webinar Series
05/01/2024 | ZESTRONZESTRON, the leading global provider of high-precision cleaning products, services, and training solutions in the electronics manufacturing and semiconductor industries, proudly announces the launch of its highly anticipated webinar series on Advanced Packaging & Power Electronics, a webinar series on the latest innovations, cleaning, and corrosion challenges.
NextFlex Convenes the Hybrid Electronics Community at Binghamton University
05/01/2024 | NextFlexBinghamton University hosted the NextFlex hybrid electronics community on April 18 for a day of expert presentations, breakout sessions on technology and manufacturing topics, and networking.
HQ NextPCB of HQ Electronics Debut on the International Stage for Electronics Manufacture at IPC APEX 2024
05/01/2024 | PRNewswireHQ NextPCB of HQ Electronics, a leading Chinese-based multilayer PCB manufacturer and assembly house showcased its industrial prowess on the international stage for the first time at the IPC APEX Expo 2024.